Check-Cap Ltd. logo

Check-Cap Ltd. (7CC)

Market Closed
16 Jun, 06:10
XFRA XFRA
1. 20
+0.03
+2.5641%
4.56M Market Cap
- P/E Ratio
- Div Yield
230 Volume
- Eps
1.17
Previous Close
Add Transaction
Day Range
1.2 1.2
Year Range
0.48 2.66
Want to track 7CC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7CC closed today higher at €1.2, an increase of 2.5641% from yesterday's close, completing a monthly decrease of -9.7744% or -€0.13. Over the past 12 months, 7CC stock lost -9.7744%.
7CC is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Check-Cap Ltd. has completed 2 stock splits, with the recent split occurring on Nov 25, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

7CC Chart

People also search for

71W
Valtecne S.p.A.
7.95
+0.6329%
ZC0
Stainless Tankers ASA
3.74
+3.0303%
KRY
Glaston Oyj Abp
1.07
+1.9048%
Z9H
Erredue S.p.A.
9.22
+1.5419%
DKC
Asia Tele-Net & Technology Ltd.
2.12
+0.9524%

Check-Cap Ltd. (7CC) FAQ

What is the stock price today?

The current price is €1.20.

On which exchange is it traded?

Check-Cap Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 7CC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.56M.

Has Check-Cap Ltd. ever had a stock split?

Check-Cap Ltd. had 2 splits and the recent split was on Nov 25, 2022.

Check-Cap Ltd. Profile

Professional Services Industry
Industrials Sector
David Lontini CEO
XFRA Exchange
IL0011336851 ISIN
IL Country
85 Employees
- Last Dividend
25 Nov 2022 Last Split
- IPO Date

Overview

Check-Cap Ltd. is a pioneering clinical stage medical diagnostics company that specializes in innovative capsule-based screening technologies designed to enhance patient health and diagnostics capabilities. Established in 2004, the company is headquartered in Isfiya, Israel and strives to revolutionize medical screening processes through its cutting-edge products. With a focus on non-invasive diagnostic solutions, Check-Cap aims to improve early detection and management of various medical conditions, particularly those within the gastrointestinal realm.

Products and Services

  • Capsule-Based Imaging Technology

    This advanced imaging technology utilizes ingestible capsules to capture high-resolution images of the digestive tract. Designed to provide non-invasive and thorough examination, this product can help detect abnormalities and diseases early on, which is critical for effective treatment.

  • Gastrointestinal (GI) Screening Tools

    Check-Cap offers specialized screening tools aimed at identifying potential issues within the gastrointestinal system. These tools combine advanced imaging and diagnostic techniques to give healthcare providers essential insights into patients' health.

  • Data Analytics and Reporting Services

    Through sophisticated data analytics, Check-Cap interprets the images and provides comprehensive reports that aid physicians in making informed decisions regarding patient care. This service ensures timely and accurate diagnoses, facilitating better patient outcomes.

  • Research and Development Initiatives

    Dedication to innovation is at the heart of Check-Cap's mission. The company actively engages in research and development to refine existing technologies and explore new applications for capsule-based diagnostics, ensuring they remain at the forefront of medical advancements.

Contact Information

Address: 29 Abba Hushi Ave.
Phone: +972 4 830 3400